Issuer · CIK 0001703057

ABCL — AbCellera Biologics Inc.

Recent filings

Jun 3, 2026·Form 4·Other$47.5K
ABCL/AbCellera Biologics Inc.
Booth Andrew · Chief Financial Officer
Mechanical filing
AI thesis skipped
May 18, 2026·Form 4·Buy$95.4K
ABCL/AbCellera Biologics Inc.
Montalbano John S. · director
52conviction

← Back to all filings